Latest filing published 17 Sept 2026 for 오리엔트바이오.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -22.3%Entry ₩524 · Close at T+90 ₩407
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
오리엔트: trading record in brief
오리엔트 is a declared insider of 오리엔트바이오, with filings sourced from DART (FSS). Between 5 December 2025 and 17 September 2026, the trades on record add up to 11 filings.
The open-market side counts 5 purchases alongside 1 sale. The amount is not disclosed for 6 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 4 purchases and 1 sale.
The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
On 17 September 2026 came the latest disclosure, a transaction in 오리엔트바이오. The most recent open-market purchase was published on 4 September 2026, 65 days ago. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 오리엔트
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0DART
- 0DART
- 0DART
- 0DART
- 877,804 sharesKRXDART:20260708000417Canonical exit: 6 Oct 2026 (T+90)
- 14,231,668 sharesShareKRXDART:20260611000186Canonical exit: 20 Aug 2026 (T+90)
- 42,235,607 sharesKRXDART:20260320000557Canonical exit: 11 Jun 2026 (T+90)
- ShareKRXDART:20260210000928Canonical exit: 11 May 2026 (T+90)
- 14,879 sharesShareKRXDART:20251205000446Canonical exit: 3 Mar 2026 (T+90)
11 of 11 declarations